Clinical trials in Alytus

Groundbreaking research focusing on ischemic stroke prevention, particularly studying new therapeutic approaches for patients who have experienced acute non-cardioembolic strokes or high-risk transient ischemic attacks.

• Post-stroke prevention strategies
• Oral anticoagulation therapy
• Mini-stroke management

Clinical investigations are evaluating novel oral medications combined with antiplatelet therapy for improved stroke prevention outcomes.

Studies targeting atherosclerotic cardiovascular disease through innovative therapeutic approaches, focusing on reducing major adverse cardiovascular events in high-risk patients.

• LDL-C level management
• Cardiovascular death prevention
• Heart attack risk reduction

Research aims to evaluate new treatments for preventing cardiovascular complications in patients with established vascular disease.

Innovative clinical trials exploring treatments for acute decompensated heart failure, with special attention to patients with preserved and mildly reduced ejection fraction.

• Heart failure event reduction
• Cardiovascular mortality
• Novel therapeutic approaches

Studies are evaluating new compounds to reduce heart failure events and improve patient outcomes.